Internal Medicine · Ponca City, OK
NPI
1396737888
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
122 E Grand Ave
Ponca City, OK, 74601
Phone (580) 302-8270
Groups this clinician bills Medicare through
Medicare paid, 2023
$9,482
129 services
Medicare patients, 2023
56
Average age 79
Drug cost, 2024
$2.2M
23,422 prescriptions
Company payments, 2025
$525
From 13 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Melinda R Allen was code 99308 (snf e&m), 23 times for 16 patients. In total Melinda R Allen billed 129 services in 14 codes, and Medicare paid $9,482.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 23 | 16 | $56.41 | $1,297 |
| 99223 Hospital E&M - Initial | Facility | 18 | 16 | $114.02 | $2,052 |
| 99239 Hospital Discharge Management | Facility | 18 | 17 | $87.34 | $1,572 |
| 99233 Hospital E&M - Subsequent | Facility | 16 | 11 | $91.20 | $1,459 |
By year: 2022 $100K for 1,721 services; 2023 $9,482 for 129 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 62 | 54 | $9.61 | $596 |
| 81003 Clinical Chemistry | 36 | 31 | $2.24 | $80.46 |
Medicare prescription drug claims, 2024
In 2024, the drug Melinda R Allen prescribed most often to Medicare patients was Levothyroxine Sodium, with 870 prescriptions and refills. In total Melinda R Allen wrote 23,422 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 870 | 1,537 | 157 | $7,587 |
| Atorvastatin Calcium Generic | 688 | 1,338 | 154 | $7,501 |
| Furosemide Generic | 678 | 1,008 | 123 | $3,973 |
| Potassium Chloride Generic | 607 | 1,020 | 132 | $8,800 |
| Gabapentin Generic | 586 | 843 | 115 | $11K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 533 | 533 | 94 | $14K |
| Amlodipine Besylate Generic | 499 | 992 | 120 | $4,300 |
| Omeprazole Generic | 483 | 896 | 99 | $7,259 |
| Eliquis Apixaban | 462 | 535 | 54 | $219K |
| Metformin Hcl Generic | 433 | 870 | 105 | $3,041 |
| Sertraline Hcl Generic | 412 | 736 | 84 | $3,790 |
| Pantoprazole Sodium Generic | 390 | 730 | 90 | $4,461 |
| Rosuvastatin Calcium Generic | 371 | 791 | 91 | $4,052 |
| Donepezil Hcl Generic | 324 | 418 | 54 | $3,820 |
| Lisinopril Generic | 314 | 575 | 63 | $2,658 |
Brand drugs: 3,882 claims; generic drugs: 19,468 claims; opioid claims: 1,275.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melinda R Allen $525 ($525 in general payments such as food, travel and fees) from 13 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $103.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $103 |
| Lilly USA, LLC LLY | 4 | $70.8 |
| GlaxoSmithKline, LLC. GSK | 3 | $57.38 |
| Abbvie Inc. ABBV | 3 | $54.09 |
| Exact Sciences Corporation EXAS | 3 | $52.59 |
| Electromed, Inc. ELMD | 3 | $37.34 |
| Pfizer Inc. PFE | 2 | $34.27 |
| Aimmune Therapeutics, Inc. | 1 | $25.32 |
| Lundbeck LLC | 1 | $24.8 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.